Curie-Cancer and GenoSplice Technology sign bioinformatics partnership agreement for application in cancer genomics

The innovative partnership is planned to run for several years to develop unique, high value added genomic approaches.

Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and GenoSplice Technology, developers of bioinformatics solutions for analysis of genomic data, today announce they have formed a partnership to combine their expertise.


Full text (pdf) in english or in french

This entry was posted in Media. Bookmark the permalink.

Comments are closed.